Stock Groups

Novavax applies to WHO for emergency listing of COVID-19 vaccine By Reuters

[ad_1]

© Reuters. FILEPHOTO: This illustration, taken on November 9, 2020, shows a Novavax logo reflected in the drop of a needle. REUTERS/Dado Ruvic/Illustration

(Reuters) – Novavax (NASDAQ:) Inc and its partner Serum Institute of India said on Thursday they had applied to the World Health Organization for an emergency use listing of Novavax’s COVID-19 vaccine.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by the exchanges. However, market makers provide accurate prices. This means that prices might not match actual market prices. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.



[ad_2]